Classification | Radioresistance group (n = 41) | Radiosensitivity group (n = 29) | P* |
---|---|---|---|
Sex | |||
Male | 35 | 23 | 0.752 |
Female | 6 | 6 | |
Age | |||
<50 | 28 | 20 | 1.000 |
≥50 | 13 | 8 | |
KPS | 90.00 ± 0.01 | 89.71 ± 1.69 | 0.321 |
Pathologic type | |||
Differentiated | 8 | 5 | 1.000 |
Undifferentiated | 33 | 24 | |
Clinical stage | |||
I | 0 | 0 | 0.883 |
II | 6 | 5 | |
III | 14 | 11 | |
Iva + IVb | 21 | 13 | |
T stage | |||
T1 | 2 | 2 | 0.693 |
T2 | 6 | 4 | |
T3 | 15 | 13 | |
T4 | 18 | 10 | |
N stage | |||
N0 | 1 | 0 | 0.694 |
N1 | 16 | 13 | |
N2 | 21 | 13 | |
N3 | 3 | 3 | |
Hemoglobin (g/l) | 137.6 ± 15.5 | 139.8 ± 17.7 | 0.577 |
PGTVnx | 71.99 ± 1.14 | 71.77 ± 1.18 | 0.437 |
PGTVnd | 68.88 ± 2.15 | 68.20 ± 2.64 | 0.243 |
CTV1 | 60.74 ± 0.98 | 60.80 ± 0.99 | 0.809 |
CTV2 | 54.72 ± 0.87 | 54.77 ± 0.90 | 0.809 |